Submit your papersSubmit Now
For Enquiries: [email protected]
IIARD LogoIIARD

Effect of Combined Oral Contraceptives on Bilirubin, Total Protein, Albumin, Aspartate Transaminase, Alanine Transaminase and Alkaline Phosphatase in Female Albino Rats

Arunsi, OM, Okogeri, E I, Kalu, NO

Abstract

Oral contraceptives (OCs) are widely utilized for reproductive health management, yet concerns persist regarding their impact on liver function, particularly due to the hepatic metabolism of synthetic hormones such as estrogen and progestin. The liver is central to protein synthesis and bilirubin clearance, making it susceptible to functional alterations induced by exogenous hormone exposure. This study aimed to evaluate the effect of oral contraceptives on key liver function biomarkers total protein, albumin, conjugated (direct) bilirubin, and unconjugated (indirect) bilirubin, in female albino rats. Ethical approval was obtained from the Madonna University Ethical Committee on the use of experimental animals. A total 30 female Wistar albino rats were randomized into three groups (n = 10 each): Group A (control), Group B (low-dose OC), and Group C (high-dose OC). After 4 weeks of oral contraceptive administration, blood samples were collected and analyzed using the Jendrassik-Grof method (bilirubin), biuret method (total protein), and bromcresol green method (albumin). Statistical analysis was performed using SPSS, with ANOVA and Tukey’s post hoc test. The mean serum albumin levels were 3.60?±?0.43?g/dL (control), 3.97?±?0.26?g/dL (low dose), and 5.12?±?0.94?g/dL (high dose), showing a significant increase (p = 0.017). Total protein levels rose from 6.68?±?0.35?g/dL (control) to 7.43?±?0.54?g/dL (low dose) and 7.78?±?0.10?g/dL (high dose) (p = 0.030). Unconjugated bilirubin values increased from 0.63?±?0.10?mg/dL (control) to 0.78?±?0.05?mg/dL (low dose) and 0.93?±?0.21?mg/dL (high dose) (p = 0.026). Conjugated bilirubin also rose significantly, with values of 0.18?±?0.05?mg/dL in both control and low-dose groups, compared to 0.40?±?0.08?mg/dL in the high-dose group (p = 0.004). The Aspartate Transaminase in the high dose group recorded a significantly higher mean value of (12: 00 ± 1.4 U/L) compared to the control (9.50 ± 1.

Keywords

Levofemestrogenprogestincontraceptivesalbuminbilirubinaspartate

References

Adaramoye, O. A., Olawale, F., & Akinmoladun, F. O. (2019). Sub-chronic exposure to estrogenic agents alters hepatic enzyme activities and antioxidant status in rats. Nigerian Journal of Physiological Sciences, 34(2), 113–120. Ahmend. S, Maureen. N, Emma W, and Saifuddin. A. (2013). Operations research to add postpartum family planning to maternal and neonatal health to improve birth spacing in sylhet District, Bangladesh. Global Health Science and practice, August 2013. El-Gohary, M. E., El-Ashmawy, I. M., & El-Nahas, A. F. (2017). Influence of oral contraceptive pills on liver function tests and histological structure of female albino rats. Asian Pacific Journal of Reproduction, 6(2), 96–100. Elliott-Sale, K. J., McNulty, K. L., Ansdell, P., Goodall, S., Hicks, K. M., Thomas, K., Swinton, P. A., & Dolan, E. (2020). The Effects of Oral Contraceptives on Exercise Performance in Women: A Systematic Review and Meta-analysis. Sports Medicine, 50(10): 1785–1812. Ezejiofor, T. I. N., Orisakwe, O. E., & Dioka, C. E. (2018). Assessment of liver function in women using combined oral contraceptives in Nnewi, Nigeria. Journal of Basic and Clinical Physiology and Pharmacology, 29(5), 491–496. Fernández Ventureira, V., Ros Arnal, I., Rodríguez Martínez, G., García Rodríguez, B., García Romero, R., & Ubalde Sainz, E. (2021). Evaluation of liver function tests in the paediatric patient. Anales de Pediatria, 94(6): 359–365 Ghoneim, F. M., Hassan, M. S., & Faddan, N. H. (2021). Hepatotoxic effects of oral contraceptives: biochemical and histopathological study in experimental rats. Egyptian Journal of Histology, 44(1), 105–115. Keerl, C., & Bernsmeier, C. (2020). [Elevated liver function tests - as incidental finding in general practice]. Therapeutische Umschau. Revue Therapeutique, 77(8): 371–378. Lashen, H., Fear, K., & Sturdee, D. W. (2018). The effects of oral contraceptives on the liver: A review of biochemical and clinical studies. Human Reproduction Update, 24(1), 1–10. Molina-Molina, E., Shanmugam, H., Di Palo, D., Grattagliano, I., & Portincasa, P. (2021). Exploring Liver Mitochondrial Function by 13C-Stable Isotope Breath Tests: Implications in Clinical Biochemistry. Methods in Molecular Biology, 2310, 179–199. Mohammed, H. A., Ahmed, M. A., & Younis, F. (2020). Serum protein changes in women using combined oral contraceptives: A biochemical evaluation. Journal of Reproductive Health and Medicine, 6(2), 61–66. Orinya, O. J., Ibrahim, N. D. G., & Ambali, S. F. (2020). Effects of ethinylestradiol-based oral contraceptives on liver function indices of female Wistar rats. Nigerian Veterinary Journal, 41(2), 131–137. Uwakwe, A. A., & Ogbulie, J. N. (2016). The effect of synthetic estrogen on liver enzymes and bilirubin metabolism in albino rats. International Journal of Biological and Chemical Sciences, 10(3), 1089–1097. Giannini, A., Saravanan, R., and Ping, Chang. (2005). Dynamics of the boreal summer African monsoon in the NSIPP1 atmospheric model. Climate Dynamics in Octobe